Clinical Trials Directory

Trials / Completed

CompletedNCT06944951

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of PROCTOeze® PLUS

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device PROCTOeze® PLUS in the Relief of Haemorrhoidal Disease and Anal Irritation Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Biokosmes Srl · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial aims to evaluate the overall performance and safety of the MD PROCTOeze® PLUS in relieving symptomatology of haemorrhoidal disease and anal irritation in adult patients affected by Grade I-II (Goligher classification) haemorrhoids as assessed by the patient and the Investigator at the end of the treatment period.

Detailed description

The protocol is based on what is already known on both the topic object of the study, i.e., the symptomatic treatment of haemorrhoids, and the investigational medical device - PROCTOeze® PLUS - which is a specific adjuvant for the symptomatic relief of internal and external haemorrhoids and anal irritation. Due to its formulation, it contributes to the physiological restoration of the anal and perianal tissues. The tool used in this research is a PMCF, a procedure which, through a scientific method of detection (one or more questionnaires to be submitted to a representative sample of patients related to the issue of the research), allows to collect, and subsequently analyse, the data needed to study the relationships between different variables.

Conditions

Interventions

TypeNameDescription
DEVICEHydrophilic emulsion for the relief of haemorroidal symptomsAdministration for 2 weeks of PROCTOeze® PLUS - a soft and light hydrophilic emulsion able to provide symptomatic relief of haemorrhoids and anal irritation.

Timeline

Start date
2024-11-05
Primary completion
2025-01-17
Completion
2025-01-17
First posted
2025-04-25
Last updated
2026-02-05
Results posted
2026-02-05

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT06944951. Inclusion in this directory is not an endorsement.